Enhanced prediction of fracture risk combining vertebral fracture status and BMD
Ethel S. Siris(Columbia University Irving Medical Center), John H. Krege(Eli Lilly (United States)), Andrew J. Laster(Bone Health and Osteoporosis Foundation), Harry K. Genant(University of California, San Francisco), P. Chen(Eli Lilly (United States)), Derek Misurski(Eli Lilly (United States))
Cited by 196
Related Papers
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
|New England Journal of Medicine|2009|3.4k
Generation and reproductive phenotypes of mice lacking estrogen receptor β
|Proceedings of the National Academy of Sciences|1998|1.7k
The clinician’s guide to prevention and treatment of osteoporosis
|Osteoporosis International|2022|1.3k
RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2 FOR TREATMENT OF OPEN TIBIAL FRACTURES
|Journal of Bone and Joint Surgery|2002|1.3k
Elevated blood pressures in mice lacking endothelial nitric oxide synthase
|Proceedings of the National Academy of Sciences|1996|903